PubRank

M R Wessels

Author PubWeight™ 68.16‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence. Proc Natl Acad Sci U S A 1987 3.99
2 Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus. Mol Microbiol 1998 3.84
3 Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci. Infect Immun 1992 2.73
4 Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection. J Clin Invest 1996 2.57
5 Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. J Clin Invest 1998 2.47
6 Structure and immunochemistry of an oligosaccharide repeating unit of the capsular polysaccharide of type III group B Streptococcus. A revised structure for the type III group B streptococcal polysaccharide antigen. J Biol Chem 1987 2.35
7 Functional analysis in type Ia group B Streptococcus of a cluster of genes involved in extracellular polysaccharide production by diverse species of streptococci. J Biol Chem 2001 2.30
8 Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A Streptococcus. Infect Immun 1997 2.13
9 Identification of cpsD, a gene essential for type III capsule expression in group B streptococci. Mol Microbiol 1993 2.09
10 Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Clin Invest 1996 2.05
11 The changing spectrum of group B streptococcal disease. N Engl J Med 1993 1.94
12 Hyaluronic acid capsule modulates M protein-mediated adherence and acts as a ligand for attachment of group A Streptococcus to CD44 on human keratinocytes. J Clin Invest 1998 1.87
13 Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci. Infect Immun 1996 1.79
14 Group A Streptococcus tissue invasion by CD44-mediated cell signalling. Nature 2001 1.76
15 Reduction of incorrect antibiotic dosing through a structured educational order form. Arch Intern Med 1988 1.59
16 Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine. Infect Immun 1994 1.53
17 Bacterial determinants of persistent throat colonization and the associated immune response in a primate model of human group A streptococcal pharyngeal infection. Cell Microbiol 2000 1.49
18 Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugates. J Clin Invest 1992 1.45
19 Structure of the has operon promoter and regulation of hyaluronic acid capsule expression in group A Streptococcus. Mol Microbiol 1998 1.30
20 Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. J Infect Dis 1999 1.30
21 CD44 as a receptor for colonization of the pharynx by group A Streptococcus. J Clin Invest 2000 1.30
22 Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine. Infect Immun 1992 1.27
23 Molecular analysis of the capsule gene region of group A Streptococcus: the hasAB genes are sufficient for capsule expression. J Bacteriol 1998 1.26
24 Characterization of the linkage between the type III capsular polysaccharide and the bacterial cell wall of group B Streptococcus. J Biol Chem 2000 1.21
25 An oligosaccharide-tetanus toxoid conjugate vaccine against type III group B Streptococcus. J Biol Chem 1990 1.18
26 Regulation of capsule gene expression by group A Streptococcus during pharyngeal colonization and invasive infection. Mol Microbiol 2001 1.10
27 Characterization of cpsF and its product CMP-N-acetylneuraminic acid synthetase, a group B streptococcal enzyme that can function in K1 capsular polysaccharide biosynthesis in Escherichia coli. Mol Microbiol 1996 1.10
28 Immunochemical analysis of the types Ia and Ib group B streptococcal polysaccharides. J Immunol 1985 1.07
29 Absence of a cysteine protease effect on bacterial virulence in two murine models of human invasive group A streptococcal infection. Infect Immun 2001 1.06
30 Group B streptococcal opacity variants. J Bacteriol 1992 1.05
31 Hormones, receptors, and cyclic AMP: their role in target cell refractoriness. Curr Top Cell Regul 1980 1.00
32 Differences between agonist and antagonist binding following beta-adrenergic receptor desensitization. J Biol Chem 1978 0.99
33 Capsular polysaccharide regulates neutrophil complement receptor interactions with type III group B streptococci. Infect Immun 1993 0.98
34 Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus. J Immunol 1999 0.95
35 Selective alteration in high affinity agonist binding: a mechanism of beta-adrenergic receptor desensitization. Mol Pharmacol 1979 0.90
36 Cloning, sequence analysis and expression of the group A streptococcal guaB gene encoding inosine monophosphate dehydrogenase. Gene 1995 0.89
37 Molecular analysis of two group B streptococcal virulence factors. Semin Perinatol 1990 0.89
38 Functional activity of antibodies to the group B polysaccharide of group B streptococci elicited by a polysaccharide-protein conjugate vaccine. Infect Immun 1994 0.89
39 Characterization of CMP-N-acetylneuraminic acid synthetase of group B streptococci. J Bacteriol 1994 0.87
40 Characterization of the capsular polysaccharide genes of group B streptococci. Dev Biol Stand 1995 0.83
41 Molecular size affects antigenicity of type III, group B Streptococcus capsular polysaccharide. Trans Assoc Am Physicians 1985 0.83
42 Hyaluronic acid capsule modulates interactions of group A streptococci with human epidermal keratinocytes. Adv Exp Med Biol 1997 0.80
43 Effect of hospitalwide change in clindamycin dosing schedule on clinical outcome. Rev Infect Dis 1989 0.79
44 Glycolipid intermediates in biosynthesis of group B streptococcal capsular polysaccharide. Adv Exp Med Biol 1997 0.77
45 Correct structure of repeating unit of group B Streptococcus type III capsular polysaccharide. J Infect Dis 1990 0.77
46 Human granulocytic ehrlichiosis presenting as facial diplegia in a 42-year-old woman. Clin Infect Dis 2000 0.76
47 Measurement of human antibodies to type III group B Streptococcus. Infect Immun 1999 0.76
48 Role of complement and complement receptor C1qR in the antibody-independent killing of group B streptococcus. Adv Exp Med Biol 1997 0.75
49 Identification of a gene similar to ABC transporters near the capsule synthesis region of the group A streptococcal chromosome. Dev Biol Stand 1995 0.75
50 Regulation of hyaluronic acid capsule production by the has operon promoter in group A streptococci. Adv Exp Med Biol 1997 0.75